Tai Chi for Arthrosis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Arthrosis
Tai Chi versus wellness education - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This exploratory study is to compares mechanisms of mind-body exercise with wellness education program on gut microbiota for osteoarthritis as a basis for a future large-scale trial.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: From Week 0, to Week 12, or to Week 24

Week 12
Gut microbiota
Week 24
Change in Body mass index
Change in Hospital Anxiety and Depression Scale
Change in Medical Outcome 36-Item Short-Form Health Survey
Week 24
Change in Western Ontario and McMaster University Index (WOMAC)

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Tai Chi
1 of 2
Wellnes Education
1 of 2

Active Control

Non-Treatment Group

25 Total Participants · 2 Treatment Groups

Primary Treatment: Tai Chi · Has Placebo Group · N/A

Wellnes Education
Behavioral
PlaceboComparator Group · 1 Intervention: Tai Chi versus wellness education · Intervention Types: Behavioral
Tai Chi
Behavioral
ActiveComparator Group · 1 Intervention: Tai Chi versus wellness education · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: from week 0, to week 12, or to week 24

Who is running the clinical trial?

Tufts Medical CenterLead Sponsor
235 Previous Clinical Trials
244,511 Total Patients Enrolled
Chenchen Wang, MD, MScPrincipal InvestigatorTufts Medical Center
5 Previous Clinical Trials
589 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have symptomatic and/or radiographic osteoarthritis of the knee.
Baseline (Month 0) WOMAC pain subscale score ≥ 40.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 2nd, 2021

Last Reviewed: November 29th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.